Report of two pedigrees with heterozygous HTRA1 variants‐related cerebral small vessel disease and literature review

Autor: Hui Zhou, Bin Jiao, Ziyu Ouyang, Qihui Wu, Lu Shen, Liangjuan Fang

Publikováno v: Molecular Genetics & Genomic Medicine, Vol 10, Iss 10, Pp n/a-n/a (2022)

Abstract Background Biallelic HTRA1 pathogenic variants are associated with autosomal recessive cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). Recent studies have indicated that heterozygous HTRA1 variants are rela

Externí odkaz: https://doaj.org/article/db179a0b7330417c9d9a9d82d1a55ca9

Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China

Autor: Xun Zhou, Jifeng Guo, Qiying Sun, Qian Xu, Hongxu Pan, Renhe Yu, Jieqiong Tan, Xinxiang Yan, Beisha Tang, Liangjuan Fang

Publikováno v: Frontiers in Neurology, Vol 10 (2019)

Background and Objectives: Studies examining the risk factors for dyskinesia in Parkinson's disease (PD) have been inconsistent, and racial differences exist. Since there have been no systematic studies of the characteristics of dyskinesia in the Mai

Externí odkaz: https://doaj.org/article/6846bfabdd6245d69d4eb74f553db33b

Detection of changes in synaptic density in amyotrophic lateral sclerosis patients using 18 F‐SynVesT ‐1 positron emission tomography

Autor: Yongxiang Tang, Pan Liu, Wanzhen Li, Zhen Liu, Ming Zhou, Jian Li, Yanchun Yuan, Liangjuan Fang, Mengli Wang, Lu Shen, Yiyun Huang, Beisha Tang, Junling Wang, Shuo Hu

Publikováno v: European Journal of Neurology. 29:2934-2943

Synaptic loss is well established as the major correlate of characteristic and consistent pathology in amyotrophic lateral sclerosis (ALS). We aimed to assess the possible discriminant diagnostic value ofsup18/supF-SynVesT-1 positron emission tomogra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d15c326ef510a4c8648d34136e9570d3
https://doi.org/10.1111/ene.15451

Clinical features of

Autor: Yun, Tian, Lu, Zhou, Jing, Gao, Bin, Jiao, Sizhe, Zhang, Qiao, Xiao, Jin, Xue, Ying, Wang, Hui, Liang, Yaling, Liu, Guang, Ji, Chenhui, Mao, Caiyan, Liu, Liling, Dong, Long, Zhang, Shugang, Zhang, Jiping, Yi, Guohua, Zhao, Yingying, Luo, Qiying, Sun, Yafang, Zhou, Fang, Yi, Xiaoyu, Chen, Chaojun, Zhou, Nina, Xie, Mengchuan, Luo, Lingyan, Yao, Yacen, Hu, Mengqi, Zhang, Qiuming, Zeng, Liangjuan, Fang, Hong-Yu, Long, Yuanyuan, Xie, Ling, Weng, Si, Chen, Juan, Du, Qian, Xu, Li, Feng, Qing, Huang, Xuan, Hou, Junpu, Wang, Bin, Xie, Lin, Zhou, Lili, Long, Ji-Feng, Guo, Junling, Wang, Xinxiang, Yan, Hong, Jiang, Hongwei, Xu, Ranhui, Duan, Beisha, Tang, Lu, Shen

Publikováno v: Journal of neurology, neurosurgery, and psychiatry. 93(12)

Abnormal expanded GGC repeats within thePatients withIn the 247 patients withNIID is not rare; however, it is usually misdiagnosed as other diseases. Our results help to extend the known clinical spectrum of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cdc6e08d38408ecb26e2aadb7058f873
https://pubmed.ncbi.nlm.nih.gov/36150844

Serological markers exploration and real-world effectiveness and safety of teriflunomide in south Chinese patients with multiple sclerosis

Autor: Ran Zhou, Hongliang Li, Huan Yang, Fei Jiang, Haobing Cai, Jing Li, Si Chen, Liangjuan Fang, Jun Yin, Qiuming Zeng

Publikováno v: Zhou, R 2022, ' Serological markers exploration and real-world effectiveness and safety of teriflunomide in south Chinese patients with multiple sclerosis ', Multiple sclerosis and related disorders, vol. 58, 103446 . https://doi.org/10.1016/j.msard.2021.103446

BackgroundSince September 2012, when teriflunomide was approved as a disease-modifying treatment for relapsing multiple sclerosis, real-world observational studies on teriflunomide in Chinese patients are limited.MethodsWe collected demographic chara

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ea99ca06e76315f4ac9caeb87e79599
https://pubmed.ncbi.nlm.nih.gov/34929454